Sun, Jul 13, 2014, 10:40 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

OneBeacon Insurance Group, Ltd. Message Board

analyst112 27 posts  |  Last Activity: Jul 10, 2014 10:41 AM Member since: Mar 30, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • analyst112 by analyst112 May 7, 2014 10:07 AM Flag

    Less overhead, higher margins, better locations and CEO just bought $650,000 worth adding 11% to his holdings along with two other insiders. Does not sound like they have WFM issues.

    Sentiment: Strong Buy

  • analyst112 by analyst112 May 7, 2014 12:38 PM Flag

    Good news-- $4 million in costs gone. Focus on the big picture---wound care--huge market

  • analyst112 by analyst112 May 1, 2014 9:28 AM Flag

    Earnings very good again and up 38% from 4Q. No issues with delinquencies or volumes. Earning at $1.50 rate. They could raise the dividend to $.30/qtr form $.11 as they have no need for added capital. Yield now 2.6%. Stock very cheap at 9x next year's earnings. Still believe they will sell out at $50 in a few years.

    Cannot explain the stock price decline. It must be one of the hedge funds liquidating. They must have expected a bad quarter or maybe the fund is liquidating. Great buying opportunity.

    Sentiment: Strong Buy

  • analyst112 by analyst112 Apr 15, 2014 11:05 AM Flag

    Google has taken your property without your consent. The non-voting shares are not as valuable as determined by the market. Therefore you are entitled to compensation for property confiscated. It is no different than if Google issued you a preferred share for your 1/2 interest. The class action will ask for just compensation not some promise to make things right.

  • analyst112 by analyst112 May 29, 2014 10:24 AM Flag

    Parent CWH changes board and Portney et.al. will be out. Since CWH controls SIR and GOV we should see a Board change at SIR. The last offering was the last straw for conflicts. SIR did not need the money and Portney did it strictly for control and monetary issues for himself. TA will also be affected for the better. With the new Board at CWH, the last SIR proxy would have failed as well as the offering. SIR is approximately 25% undervalued relative to the REIT index so we have good upside.

  • analyst112 by analyst112 Jul 10, 2014 10:41 AM Flag

    Let's hope GOV keeps dropping. That will encourage activists to take a position. GOV is widely held and I do not think major shareholders think buying a conflicted stock at above market prices is a good idea. The BS is also levered enough that they cannot lever more to buy properities.

  • Reply to

    launch for stock price

    by analyst112 Jun 23, 2014 11:35 AM
    analyst112 analyst112 Jun 27, 2014 10:26 AM Flag

    ORBC will have to depreciated the birds and this non-cash charge is a deduction from earnings. Cash flow will be up and strong and that is what counts.

  • analyst112 by analyst112 Jul 3, 2014 1:10 PM Flag

    We use 50 million pounds a year so do the math on the EPA phaseout schedule.
    What the EPA is calling its “preferred HCFC-22 consumption allocation for 2015-2019” shows a production allowance of 30 million pounds in 2015, 24 million pounds in 2016, 18 million pounds in 2017, 12 million pounds in 2018, 6 million pounds in 2019, and zero in 2020. If you believe in economics, prices will rise to meet supply reductions. The production decline in 2015 is 22 million pounds over 2014 and that is 6 months from now. The price rise could be dramatic. Reclaimed product prices are the only game in town after 2019 so guess what kind of prices we will see. Hudson will be $20/shr on $2.00 of earnings or higher.

  • Reply to

    Patents at risk

    by analyst112 Apr 30, 2014 10:09 AM
    analyst112 analyst112 May 1, 2014 11:13 AM Flag

    May go to $200 if they uphold but will go to $80 if Natco wins. I say it is trading as if CELG has won.

  • analyst112 by analyst112 May 13, 2014 11:30 AM Flag

    ROE 23%, ROA 8% growing at 25% with Affordable Care Act tailwind. Only 13.6 x earnings for 25% growth. The growth is in new reimbursements from ACA. 40% of trips are either not paid or paid at Medicaid rates. ACA will pay at Medicare scheduled rates. This is all found money for AIRM which fall to the bottom line. AIRM always has highly volitile 1Q's due to weather. This provides a buying opportunity. The 20% short interest will provide a short covering opportunity. AIRM will sell out to private equity at some point as cash flows are very high and stable. PHII is another company with a medical evac sub that will be acquired.

    Sentiment: Strong Buy

  • analyst112 by analyst112 Apr 15, 2014 11:56 AM Flag

    $6.20/shr of excess cash after 2:1 current ratio. That could earn $.62/shr if deployed and it earned only 10% ROE. The stock is selling at 10.7 times 2014 earnings and 9.7x next years earnings--far too cheap. UFPT has upside to $30/shr short term which is 13x 2015 earnings --below a market PE. Thye earn better returns that the SPX. Go figure.

    Sentiment: Strong Buy

  • analyst112 by analyst112 Apr 15, 2014 11:36 AM Flag

    1.5 x book value. That is very cheap for a niche bank with 2.7% ROA and 12% ROE. The balance sheet would allow leverage of earnings to $3/shr without any additional capital. That would be an ROA of 3.1% and an ROE of 20%. At those returns, they could sell the bank for 3x BV or $50/shr. There is a lot of upside again since the price decline. Some money manager got fired and the new manager is just blowing out the position. It will end at some point and then back to $27. Note that the KRE bank stock fund is selling at 2.1 x tangible BV and 1.5x stated book value. We should be at premium to that.

    Sentiment: Strong Buy

  • analyst112 by analyst112 Apr 30, 2014 10:09 AM Flag

    If Natco (Activis) prevails in the patent litigation against CELG, the stock will crater. Revlimid is $5 billion in sales for CELG or 65%. Even if they win at the lower level, Activis will appeal. Companies with patent suits on their major drug are dangerous places to be. CELG other drug are years away from approval.

  • analyst112 analyst112 May 22, 2014 12:28 PM Flag

    Unfortunately, it is all over. We had a huge position in the company and recently sold all shares. You are right on the money. They will be out of money in Q4 and the asset sale will be for very little as the business is BE according to CC. They have been through to Windows cycles and no traction. I consider it a gift that I can get $1.20/shr because I think it will be $.50 in 9 months. The two hedge funds are in serious trouble.

  • CSE is earning less than PACW and ended up with 55% of the combined company plus a slug of cash. What is PACW thinking? This could take us back to $28/shr. There are now 100 million shares out. CSE is not a good fit or good franchise.

    Sentiment: Strong Sell

  • analyst112 by analyst112 May 13, 2014 10:31 AM Flag

    Revs down, earnings down, EBITDA down. What 's to like here--clearly lost momentum. Forecast of .earnings weak and only $.06-.10/shr. I want to see progress.

    Sentiment: Sell

  • Reply to

    I Asked

    by plpjap Jul 2, 2014 1:20 PM
    analyst112 analyst112 Jul 2, 2014 3:45 PM Flag

    It is on its way to $30/lb. Suggest your boss lay in a 5 year supply. With phaseout close, the reclaimed Hudson R-22 is the only game in town.

  • analyst112 by analyst112 Jun 23, 2014 11:35 AM Flag

    If you own this because they are launching, you are sure a dumb as. ORBC's new birds will be the most powerful, broadest coverage units in the sky. The business is growing 15%/year and Iridium is the only competitor. Iridium's birds are not new gen, It will also cost them $20 million each to get them up and so their costs will be higher than ORBC whose birds will cost $7MM each to launch. ORBC will be a big company with fixed costs so all revs will fall to the bottom line.

    It is frustrating that Spacex Falcon 9 is having so much trouble but better safe than sorry. (ORBC has launch insurance also)There is no question that they will be in orbit soon as they have priority loading. To buy this stock as a day trade on launch is just dumb. Are there that many stupid people out there?

  • analyst112 by analyst112 Jul 2, 2014 11:46 AM Flag

    They cannot overcome the massive interest payments to Oaktree and others at 12% or $17 million/year annual rate. They would have to increase sales by 40% just to overcome the interest payment. They would still be losing money at that point. They have a commodity business. The equity is a mere call option on survival. Unfortunately, the next downturn will finish them off. Oaktree will get what it deserves. They are carrying it in their funds at cost--get serious.

    Sentiment: Sell

  • Reply to

    New breathing room; now expand into iOt

    by drainwire Jul 1, 2014 8:40 AM
    analyst112 analyst112 Jul 1, 2014 3:41 PM Flag

    They will now burn cash at $6MM/qtr as they lost cash flow. They are becoming irrrevelent and we have been through two windows cycles. I view this as a lucky opportunity to exit.

    Sentiment: Sell

OB
15.38+0.03(+0.20%)Jul 11 4:02 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Turtle Beach Corporation
NasdaqGMFri, Jul 11, 2014 4:00 PM EDT
Potbelly Corporation
NasdaqGSFri, Jul 11, 2014 4:00 PM EDT